Ioflupane - brand name or equal
Active Awarded Last action
- Contract number
- 36C24426N0280
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI ZL79MXYVNDM1
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $132,000
Award facts
- Contract value 100% obligated
- $132,000.00 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Integrated Service Network 4 (VISN 4) awarded a $132,000 firm fixed-price blanket purchase agreement (BPA) call to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) for the supply of Ioflupane radiopharmaceutical products. The award, issued on January 17, 2026, with an ultimate completion date of January 16, 2027, will support nuclear medicine diagnostic imaging procedures at VA medical facilities in the Philadelphia, Pennsylvania area. As a small disadvantaged business specializing in the manufacturing and distribution of radiopharmaceuticals and medical isotopes, Jubilant Radiopharma serves as a critical supplier to the VA's nationwide network, with no set-aside designation applied to this procurement, indicating open competition for the requirement.
This BPA call represents a delivery order under Jubilant Radiopharma's existing indefinite delivery vehicle with VISN 4, reflecting the network's ongoing reliance on the company's specialized capabilities in radiopharmaceutical supply chain management. The vendor maintains an extensive portfolio of IDV contracts across multiple VA networks, with individual vehicle values ranging from approximately $220,000 to $39.8 million, demonstrating the VA's substantial commitment to maintaining reliable access to advanced diagnostic and therapeutic nuclear medicine products for veteran patients. Jubilant Radiopharma's continued engagement across numerous VISNs underscores its established capability to meet stringent federal requirements for regulatory compliance, quality control, and rapid delivery of time-sensitive radiopharmaceutical materials.
Quick answers
Who was awarded contract 36C24426N0280?
36C24426N0280 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on January 17, 2026.
How much is contract 36C24426N0280 worth?
The government has obligated $132,000 on 36C24426N0280.
Is contract 36C24426N0280 an order under another contract?
Yes. 36C24426N0280 is a BPA call under 36C24425A0011, a blanket purchase agreement.
Was contract 36C24426N0280 competed?
The extent of competition for 36C24426N0280 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award